Researchers Identify Potential Targets For The Mostdeadly Form Of Pancreatic Cancer | Latest News RSS Feed

Researchers Identify Potential Targets For The Mostdeadly Form Of Pancreatic Cancer - Latest News

Beating the pancreatic cancer odds

When the scan revealed pancreatic ... Research and Cancer Council Victoria, among other organisations, have made a breakthrough. They’ve invented a new drug, known as AMP945, which targets ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

Five Areas of Exciting New Lung Cancer Research

More than 25% of patients with an adenocarcinoma type of non-small cell lung cancer have a biomarker that corresponds to an FDA-approved targeted therapy drug. As researchers continue to identify new ... read more

Verastem Oncology Announces New Data Published in The Lancet Oncology Supports Potential of VS-6766 as Treatment for RAS Mutant Tumors

(Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced new data have been published today in ... read more

Looking for other news?

Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral CDK7 Inhibitor, at EORTC-NCI-AACR Meeting

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced initial safety, pharmacokinetics (PK) and pharmacodynamics (PD) data ... read more

Tackling tumour scar tissue could be key to treating pancreatic cancer

“We are excited to uncover new potential targets for treatment of patients with pancreatic cancer. Scar tissue is a huge barrier in treating pancreatic cancer, where it can form up to 90 per cent of ... read more

Cellaria, Inc. Introduces A New Generation Of Cell Line Models For Pancreatic Cancer Paving The Way For Better Treatment

Difficult to detect and with a poor survival rate, Pancreatic Cancer remains a primary and illusive therapeutic target ... researchers to select promising compounds and ultimately identify the ... read more

Bellicum Announces Interim BPX-601 Data and Corporate Restructuring

today announced interim data from its BPX-601 dose-escalation clinical trial in patients with relapsed/refractory metastatic pancreatic cancer. Findings from the first four patients treated with ... read more

OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19

PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) ... read more

Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19

PRNewswire/ --, (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us